glp-1 and gip receptors GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Gut hormone-based pharmacology: novel formulations

Name: glp-1 and gip receptors GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Gut hormone-based pharmacology: novel formulations
Brand: buntepalette-gmbh.de
SKU: 35711065722
Price: 26.30 USD
Availability: InStock
Rating: 4.817200000000001 (17 reviews)

SKU: 35711065722

4.8

EUR26.30 EUR72.30

Pay in 4 interest-free payments of $6.58 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

Gut hormone based pharmacology: novel formulations and future possibilities for metabolic disease therapy Diabetologia Springer Nature Link GLP 1 Receptor Agonists New England Journal of Medicine GIP Receptor Agonism Attenuates GLP 1 Receptor Agonist Induced Nausea and Emesis in Preclinical Models Hayes Lab GLP 1 and GIP receptor signaling in beta cells A review of receptor interactions and co stimulation ScienceDirect

Store: buntepalette-gmbh.de · Domain: buntepalette-gmbh.de

Description

Lyophilized: store at 20 C (4 F)

doi: 10.1016/J.BIOPHA.2016.09.009

Statistical analysis Based on treatment effect size reported in a previous carnitine study in Alzheimer's disease, 19 a sample size of 59 patients in each treatment arm (118 in total) yielded an estimated effect size of 0.05 with 80% power to detect a 3.74 mean difference in MMSE